Andrew Epstein

Special Counsel
Full contact info

I solve problems

Passions

Family

Backpacking

Pittsburgh

Experience

LegalZoom Announces Acquisition of Formation Nation

February 10, 2025

Cooley advised LegalZoom (Nasdaq: LZ), an online platform for legal services, on its acquisition of Formation Nation, a small-business services company.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Erin J. Kirchner
Partner, Chicago
Nathan Baum
Special Counsel, New York
Scott Dailard
Partner, San Diego
Ross Eberly
Partner, Santa Monica
Charles Haley
Partner, Palo Alto
C. Thomas Hopkins
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Jeremy Morrison
Partner, Washington, DC
Addison Pierce
Partner, Chicago
Jonathan Rivinus
Partner, Colorado
Logan Tiari
Partner, Los Angeles
John-Paul Motley
Partner in Charge, Los Angeles, Los Angeles
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Ana A. Bordallo
Associate, San Diego
Caitlin Breitenbruck
Associate, Seattle
Alexander Ellebracht
Associate, Palo Alto
Emma Frerichs
Associate, Chicago
Liza Hadley
Associate, Boston
Allison Kutner
Associate, New York
Eileen Leman
Associate, Los Angeles
Patrick Reed
Associate, Palo Alto
Leanne Andrepont
Senior Trademark Paralegal
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Alumis Announces Merger With ACELYRIN

February 6, 2025

Cooley advised Alumis (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, on its definitive agreement with ACELYRIN to merge in an all-stock transaction.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Polina A. Demina
Special Counsel, New York
Sangitha Palaniappa
Associate, Palo Alto
Christine Turner
Associate, Colorado
Shaun (Tianjie) Wang
Associate, New York
Megan Browdie
Partner, Washington, DC
Lauren Creel
Partner, Palo Alto
Ross Eberly
Partner, Santa Monica
Stephanie Gentile
Partner, New York
Dr. Kate Hillier
Partner, Palo Alto
Sarah Lightdale
Partner, New York
Phil Mitchell
Partner, New York
Jeremy Morrison
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
Jennifer Raab
Partner, Palo Alto
Patrick Van Eecke
Partner, Brussels
Natasha Leskovsek
Of Counsel, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Caroline Vu
Special Counsel, Palo Alto
Christopher Andrews
Associate, New York
Dannielle Antone
Associate, San Francisco
Elizabeth Caruso
Associate, New York
Tamara Chin Loy
Associate, Washington, DC
Navya Dasari
Associate, New York
Joshua Elefant
Associate, Palo Alto
Winda Fung
Associate, Santa Monica
Gary Warren Hunt III
Associate, Washington, DC
Rachel F. Katz
Special Counsel, New York
Wyatt Kernell
Associate, Colorado
Kristina Krasnikova
Associate, Palo Alto
Sunny J. Levine
Associate, Colorado
Amanda Lindner
Associate, New York
Jayne M. Munger
Associate, New York
Julianne Orr
Associate, San Francisco
Michael Pelle
Associate, New York
Breanna Qin
Associate, Palo Alto
Bartholomäus Regenhardt
Associate, Brussels
Jesse Schulman
Associate, Colorado
Freddy Yip
Associate, Hong Kong
Isabella Ysebrands
Associate, San Francisco

Related Practices & Industries

Inmagene Biopharmaceuticals Announces Merger With Ikena Oncology

December 23, 2024

Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Rama Padmanabhan
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Asa Henin
Partner, San Diego
Matthew D. Silverman
Special Counsel, Santa Monica
Lindsey O'Crump
Associate, Washington, DC
Brittany K. Wightman
Associate, San Diego
Jiqiang Lin
Associate, New York
Leina Verrier
Associate, Santa Monica
Ross Eberly
Partner, Santa Monica
Stephanie Gentile
Partner, New York
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Howard Morse
Senior Counsel, Washington, DC
Alessandra Murata
Partner, Palo Alto
Jean Park
Partner, New York
Aaron Pomeroy
Partner, Colorado
Michelle Garcia Schulman
Partner, Reston
Ellie Seber
Partner, Santa Monica
Marty Schenker
Senior Counsel , San Francisco
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Stella Sarma
Partner, Brussels
Karen Tsai
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Ajay Athavale
Associate, San Francisco
Rajdeep Roger Bains
Associate, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Adrienne Beaudoin Deshmukh
Associate, Reston
Jeremy M. Exelbert
Associate, New York
Daniel Gillon
Associate, San Diego
Zack Gong
Associate, Shanghai
Rick Jantz
Associate, Santa Monica
Wyatt Kernell
Associate, Colorado
Rebeca Kinslow
Associate, San Diego
Hilda Li
Associate, Hong Kong
Lunga Su
Associate, Shanghai
Novak Topalovic
Associate, San Diego
Tania Soris
Associate, New York
Christine Tse
Associate, New York
Monica Xu
Special Counsel, Shanghai
Sai Yarramalla
Associate, Palo Alto
Andy Zachrich
Associate, San Francisco
Zheng Zhou
Associate, Palo Alto
Patricia Myers
Paralegal Specialist, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York

Related Practices & Industries

Tvardi Therapeutics Announces Merger With Cara Therapeutics

December 18, 2024

 

Cooley advised Tvardi Therapeutics, a privately held, clinical-stage biopharmaceutical company focused on the development of novel, oral, small-molecule therapies targeting STAT3 to treat fibrosis-driven diseases, on its definitive merger agreement to combine in an all-stock transaction with Cara Therapeutics (Nasdaq: CARA), a development-stage biopharmaceutical company that has been leading a new treatment paradigm to improve the lives of patients suffering from pruritus.

Read more

Related contacts

Div Gupta
Partner, New York
Rama Padmanabhan
Partner, San Diego
Carlos Ramirez
Partner, San Diego
Matthew D. Silverman
Special Counsel, Santa Monica
Anitha Anne
Special Counsel, San Francisco
Lindsey O'Crump
Associate, Washington, DC
Brittany K. Wightman
Associate, San Diego
Michael Bergmann
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Lila Hope
Partner, Palo Alto
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Howard Morse
Senior Counsel, Washington, DC
Francis Wheeler
Senior Counsel, Colorado
Natasha Leskovsek
Of Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Reid Hooper
Special Counsel, Washington, DC
Justin Kisner
Special Counsel, Palo Alto
Dani Nazemian
Special Counsel, San Diego
Stella Sarma
Partner, Brussels
Karen Tsai
Special Counsel, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Navya Dasari
Associate, New York
Jeremy Gentile
Associate, San Diego
Carly E. Gibbons
Associate, Chicago
Rachel F. Katz
Special Counsel, New York
Wyatt Kernell
Associate, Colorado
Jiqiang Lin
Associate, New York
Kelly McCormick
Associate, San Francisco
Jonathan Perez-Reyzin
Associate, San Diego
Carly Robinson
Associate, Reston
Jesse Schulman
Associate, Colorado
Rebecca Siegel
Associate, San Francisco
Tania Soris
Associate, New York
Dionne A. Thomas
Associate, San Diego
Christine Tse
Associate, New York
Patricia Myers
Paralegal Specialist, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Kura Oncology Announces Global Strategic Collaboration With Kyowa Kirin

November 20, 2024

Cooley advised clinical-stage biopharmaceutical company Kura Oncology (Nasdaq: KURA) on its global strategic collaboration with Kyowa Kirin to develop and commercialize ziftomenib, Kura’s selective oral menin inhibitor that is being investigated for the treatment of acute myeloid leukemia and other hematologic malignancies.

Read more

Related contacts

Charity Williams
Partner, San Diego
Dr. Chen Chen
Partner, Boston
Jonathan Kaufman
Associate, Palo Alto
Aaron Pomeroy
Partner, Colorado
Todd Gluth
Partner, San Diego
Amanda Pacheco
Associate, Palo Alto
Howard Morse
Senior Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Charles Bair
Partner, San Diego
Andrew Epstein
Special Counsel, Seattle
Rachel Thorn
Partner, New York
Wade Andrews
Special Counsel, San Diego
María Álvarez Requejo Heredero
Associate, Brussels
Zhijing Yu
Associate, Singapore
Natasha Leskovsek
Of Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC

Related Practices & Industries

View more

Admissions and credentials

Colorado (inactive)

Illinois (inactive)

Washington

Rankings and accolades

Chambers USA: Privacy & Data Security: Healthcare – Nationwide (2024)

Memberships and affiliations

International Association of Privacy Professionals

Washington Bar Association